A 65 year old man attends for his heart failure review. He reports ongoing reduced exercise tolerance despite taking Ramipril 5mg twice daily. His New York Heart Association (NYHA) classification is class II. On examination, his JVP and chest sounds are normal, and there is no peripheral oedema.
What is the most appropriate next step in the management of his condition?
